Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.

Autor: Vosburg SK; Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO., Severtson SG; Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO., Dart RC; Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO; Department of Emergency Medicine, University of Colorado School of Medicine, Denver, CO., Cicero TJ; Department of Psychiatry, Washington University in St. Louis, St. Louis, MO., Kurtz SP; Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL., Parrino MW; American Association for the Treatment of Opioid Dependence, New York, NY., Green JL; Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO. Electronic address: radarspublications@rmpdc.org.

Publikováno v: The journal of pain [J Pain] 2018 Apr; Vol. 19 (4), pp. 439-453. Date of Electronic Publication: 2017 Dec 07.

Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.

Autor: Severtson SG; Rocky Mountain Poison and Drug Center, 777 Bannock Street, Mailcode 0180, Denver, CO, 80204, USA. Electronic address: Geoff.Severtson@rmpdc.org., Ellis MS; Department of Psychiatry, Washington University School of Medicine, Washington University School of Medicine, Box 8134, 660 S Euclid, St. Louis, MO, 63110, USA. Electronic address: ellism@psychiatry.wustl.edu., Kurtz SP; Center for Applied Research on Substance Use and Health Disparities, Department of Justice and Human Services, College of Humanities, Arts and Social Sciences, Nova Southeastern University, 7255 NE 4th Avenue, Suite 112, Miami, FL, 33138, USA. Electronic address: Steven.kurtz@nova.edu., Rosenblum A; American Association for the Treatment of Opioid Dependence, New York, NY, USA. Electronic address: Rosenblum@ndri.org., Cicero TJ; Department of Psychiatry, Washington University School of Medicine, Washington University School of Medicine, Box 8134, 660 S Euclid, St. Louis, MO, 63110, USA. Electronic address: cicerot@psychiatry.wustl.edu., Parrino MW; American Association for the Treatment of Opioid Dependence, New York, NY, USA. Electronic address: Mark.Parrino@aatod.org., Gilbert MK; Epidemico, Inc., 50 Milk St., 20th floor, Boston, MA, 02109, USA. Electronic address: michael@epidemico.com., Buttram ME; Center for Applied Research on Substance Use and Health Disparities, Department of Justice and Human Services, College of Humanities, Arts and Social Sciences, Nova Southeastern University, 7255 NE 4th Avenue, Suite 112, Miami, FL, 33138, USA. Electronic address: mance.buttram@nova.edu., Dasgupta N; Epidemico, Inc., 50 Milk St., 20th floor, Boston, MA, 02109, USA. Electronic address: nabarun@epidemico.com., BucherBartelson B; Rocky Mountain Poison and Drug Center, 777 Bannock Street, Mailcode 0180, Denver, CO, 80204, USA. Electronic address: Becki.Bucher-Bartelson@rmpdc.org., Green JL; Rocky Mountain Poison and Drug Center, 777 Bannock Street, Mailcode 0180, Denver, CO, 80204, USA. Electronic address: Jody.Green@rmpdc.org., Dart RC; Rocky Mountain Poison and Drug Center, 777 Bannock Street, Mailcode 0180, Denver, CO, 80204, USA. Electronic address: rdart@rmpdc.org.

Publikováno v: Drug and alcohol dependence [Drug Alcohol Depend] 2016 Nov 01; Vol. 168, pp. 219-229. Date of Electronic Publication: 2016 Oct 03.

Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.

Autor: Parrino MW; a American Association for the Treatment of Opioid Dependence (AATOD), New York , New York , USA., Maremmani AG, Samuels PN, Maremmani I

Publikováno v: Journal of addictive diseases [J Addict Dis] 2015; Vol. 34 (2-3), pp. 255-62.